Global Nanomaterial-Based Adjuvants Vaccine Competitive Landscape Professional Research Report 2024

Research Summary

Nanomaterial-based adjuvants in vaccines refer to the incorporation of nanoscale materials into vaccine formulations to enhance immune responses. Adjuvants are substances added to vaccines to improve their effectiveness by stimulating the immune system. Nanomaterials such as liposomes, nanoparticles, or nanoemulsions can be engineered to carry vaccine antigens and deliver them to immune cells, leading to a stronger and more targeted immune response. These nanomaterial-based adjuvants can improve antigen stability, increase antigen uptake by immune cells, and promote immune cell activation, resulting in enhanced antibody production and a more robust immune memory. Moreover, nanomaterials can also be surface-engineered to improve targeting, controlled release, and stability of vaccines. The use of nanomaterial-based adjuvants in vaccine formulations holds promise in developing effective vaccines against infectious diseases, cancer, and other conditions.

According to DIResearch's in-depth investigation and research, the global Nanomaterial-Based Adjuvants Vaccine market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Nanomaterial-Based Adjuvants Vaccine include Emergent BioSolutions, Sanofi, GlaxoSmithKline Biologicals, Merck, Pfizer, Novartis, Moderna etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Nanomaterial-Based Adjuvants Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nanomaterial-Based Adjuvants Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nanomaterial-Based Adjuvants Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nanomaterial-Based Adjuvants Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nanomaterial-Based Adjuvants Vaccine Include:

Emergent BioSolutions

Sanofi

GlaxoSmithKline Biologicals

Merck

Pfizer

Novartis

Moderna

Nanomaterial-Based Adjuvants Vaccine Product Segment Include:

Aluminium Hydroxides

Aluminium Phosphate

Lipidosome

Others

Nanomaterial-Based Adjuvants Vaccine Product Application Include:

Pneumococcus

Human Papilloma Virus

DTaP

Viral Hepatitis TypeA

Viral Hepatitis TypeB

SARS-CoV-2

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nanomaterial-Based Adjuvants Vaccine Industry PESTEL Analysis

Chapter 3: Global Nanomaterial-Based Adjuvants Vaccine Industry Porter's Five Forces Analysis

Chapter 4: Global Nanomaterial-Based Adjuvants Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Nanomaterial-Based Adjuvants Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Nanomaterial-Based Adjuvants Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Nanomaterial-Based Adjuvants Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Nanomaterial-Based Adjuvants Vaccine Market Overview

1.1 Product Definition and Statistical Scope

1.2 Nanomaterial-Based Adjuvants Vaccine Product by Type

1.2.1 Global Nanomaterial-Based Adjuvants Vaccine Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Aluminium Hydroxides

1.2.3 Aluminium Phosphate

1.2.4 Lipidosome

1.2.5 Others

1.3 Nanomaterial-Based Adjuvants Vaccine Product by Application

1.3.1 Global Nanomaterial-Based Adjuvants Vaccine Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Pneumococcus

1.3.3 Human Papilloma Virus

1.3.4 DTaP

1.3.5 Viral Hepatitis TypeA

1.3.6 Viral Hepatitis TypeB

1.3.7 SARS-CoV-2

1.3.8 Others

1.4 Global Nanomaterial-Based Adjuvants Vaccine Market Revenue and Sales Analysis

1.4.1 Global Nanomaterial-Based Adjuvants Vaccine Market Size Analysis (2019-2030)

1.4.2 Global Nanomaterial-Based Adjuvants Vaccine Market Sales Analysis (2019-2030)

1.4.3 Global Nanomaterial-Based Adjuvants Vaccine Market Sales Price Trend Analysis (2019-2030)

1.5 Nanomaterial-Based Adjuvants Vaccine Market Development Status and Trends

1.5.1 Nanomaterial-Based Adjuvants Vaccine Industry Development Status Analysis

1.5.2 Nanomaterial-Based Adjuvants Vaccine Industry Development Trends Analysis

2 Nanomaterial-Based Adjuvants Vaccine Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Nanomaterial-Based Adjuvants Vaccine Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Nanomaterial-Based Adjuvants Vaccine Market Analysis by Regions

4.1 Nanomaterial-Based Adjuvants Vaccine Overall Market: 2023 VS 2024 VS 2030

4.2 Global Nanomaterial-Based Adjuvants Vaccine Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Nanomaterial-Based Adjuvants Vaccine Revenue and Market Share by Region (2019-2024)

4.2.2 Global Nanomaterial-Based Adjuvants Vaccine Revenue Forecast by Region (2025-2030)

4.3 Global Nanomaterial-Based Adjuvants Vaccine Sales and Forecast Analysis (2019-2030)

4.3.1 Global Nanomaterial-Based Adjuvants Vaccine Sales and Market Share by Region (2019-2024)

4.3.2 Global Nanomaterial-Based Adjuvants Vaccine Sales Forecast by Region (2025-2030)

4.4 Global Nanomaterial-Based Adjuvants Vaccine Sales Price Trend Analysis (2019-2030)

5 Global Nanomaterial-Based Adjuvants Vaccine Market Size by Type and Application

5.1 Global Nanomaterial-Based Adjuvants Vaccine Market Size by Type

5.1.1 Global Nanomaterial-Based Adjuvants Vaccine Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Nanomaterial-Based Adjuvants Vaccine Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Nanomaterial-Based Adjuvants Vaccine Market Size by Application

5.2.1 Global Nanomaterial-Based Adjuvants Vaccine Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Nanomaterial-Based Adjuvants Vaccine Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Nanomaterial-Based Adjuvants Vaccine Market Size by Type

6.3.1 North America Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

6.3.2 North America Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

6.4 North America Nanomaterial-Based Adjuvants Vaccine Market Size by Application

6.4.1 North America Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

6.4.2 North America Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

6.5 North America Nanomaterial-Based Adjuvants Vaccine Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Nanomaterial-Based Adjuvants Vaccine Market Size by Type

7.3.1 Europe Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

7.3.2 Europe Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

7.4 Europe Nanomaterial-Based Adjuvants Vaccine Market Size by Application

7.4.1 Europe Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

7.4.2 ? Europe Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

7.5 Europe Nanomaterial-Based Adjuvants Vaccine Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Nanomaterial-Based Adjuvants Vaccine Market Size by Type

8.3.1 China Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

8.3.2 China Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

8.4 China Nanomaterial-Based Adjuvants Vaccine Market Size by Application

8.4.1 China Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

8.4.2 China Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Market Size by Type

9.3.1 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

9.4 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Market Size by Application

9.4.1 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

9.5 APAC (excl. China) Nanomaterial-Based Adjuvants Vaccine Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Nanomaterial-Based Adjuvants Vaccine Market Size by Type

10.3.1 Latin America Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

10.3.2 Latin America Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

10.4 Latin America Nanomaterial-Based Adjuvants Vaccine Market Size by Application

10.4.1 Latin America Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

10.4.2 Latin America Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

10.5 Latin America Nanomaterial-Based Adjuvants Vaccine Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Market Size by Type

11.3.1 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Sales by Type (2019-2030)

11.3.2 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Revenue by Type (2019-2030)

11.4 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Market Size by Application

11.4.1 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Sales by Application (2019-2030)

11.4.2 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Revenue by Application (2019-2030)

11.5 Middle East & Africa Nanomaterial-Based Adjuvants Vaccine Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Nanomaterial-Based Adjuvants Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Nanomaterial-Based Adjuvants Vaccine Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Nanomaterial-Based Adjuvants Vaccine Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Nanomaterial-Based Adjuvants Vaccine Average Sales Price by Manufacturers (2020-2024)

12.2 Nanomaterial-Based Adjuvants Vaccine Competitive Landscape Analysis and Market Dynamic

12.2.1 Nanomaterial-Based Adjuvants Vaccine Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Emergent BioSolutions

13.1.1 Emergent BioSolutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Emergent BioSolutions Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.1.3 Emergent BioSolutions Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Sanofi

13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Sanofi Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.2.3 Sanofi Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 GlaxoSmithKline Biologicals

13.3.1 GlaxoSmithKline Biologicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 GlaxoSmithKline Biologicals Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.3.3 GlaxoSmithKline Biologicals Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Merck

13.4.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Merck Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.4.3 Merck Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Pfizer

13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Pfizer Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.5.3 Pfizer Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Novartis

13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Novartis Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.6.3 Novartis Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Moderna

13.7.1 Moderna Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Moderna Nanomaterial-Based Adjuvants Vaccine Product Portfolio

13.7.3 Moderna Nanomaterial-Based Adjuvants Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Nanomaterial-Based Adjuvants Vaccine Industry Chain Analysis

14.2 Nanomaterial-Based Adjuvants Vaccine Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Nanomaterial-Based Adjuvants Vaccine Typical Downstream Customers

14.4 Nanomaterial-Based Adjuvants Vaccine Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support